C12N 2770/32062
By genetic engineering
Official title: by genetic engineering
C12N2770/32062 (By genetic engineering) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 4
- Inventors
- 24
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Coxsackievirus b4 strain and application thereof9 Jan 2025US 2025/0009867 A1Institute of Medical Biology, Chinese Academy of Medical Sciences
- Encapsulated rna polynucleotides and methods of use11 Apr 2024US 2024/0115636 A1ElevateBio Technologies, Inc.
- Senecavirus a virus strains and immunogenic compositions therefrom11 Aug 2022US 2022/0249650 A1South Dakota Board of Regents
- Method for preparing virus-like particle and recombinant baculovirus used therein2 Apr 2015US 2015/0093804 A1National Tsing Hua University
- Method for preparing virus-like particle and recombinant baculovirus used therein26 Sep 2013US 2013/0252311 A1National Tsing Hua University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.